Literature DB >> 26629201

Clinical features of ischemic hepatitis caused by shock with four different types: a retrospective study of 328 cases.

Gang Guo1, Xian-Zheng Wu1, Li-Jie Su1, Chang-Qing Yang2.   

Abstract

The aim of the study was to investigate the clinical features of ischemic hepatitis due to shock with four different types (allergic shock, hypovolemic shock, septic shock, and cardiogenic shock). A total of 328 patients (200 males, 128 females, mean age, 65.84 ± 15.21 years old, range, 15-94 years) diagnosed with shock in Tongji Hospital were retrospectively investigated from Jun 2008 to Feb 2010. The parameters of liver function test, including alanine aminotransferanse (ALT), aspartate aminotransferanse (AST), lactate dehydrogenase (LDH), total bilirubin (TB), alkaline phosphatase (ALP) and γ-glutamyltransferase (γ-GT), were recorded and analyzed. Besides, the serum levels of C-reactive protein (CRP) and brain natriuretic peptide (BNP) were also measured and relevant correlation analysis was conducted. Among all the cases, 242 (73.8%) patients developed ischemic hepatitis. The mortality of shock patients combined with ischemic hepatitis was significantly higher than the total mortality (26.0% vs 23.8%, P < 0.05). The incidence of hepatic damage was highest in the septic shock (87.5%), while the lowest in thehypovolemic shock (49.4%). The sensitivity of ALT elevation was higher than that of AST. In addition, CRP was positively correlated with the levels of liver function parameters in the septic shock and BNP was positively correlated with that in the cardiogenic shock. Ischemic hepatitis is a common complication of shock, increasing the mortality of shock patients. The septic shock is the most common cause of hepatic damage in shock patients. CRP may be a useful predictor for septic shock, while BNP may be a useful predictor for cardiogenic shock.

Entities:  

Keywords:  Ischemic hepatitis; allergic; cardiogenic; hypovolemic; septic; shock

Year:  2015        PMID: 26629201      PMCID: PMC4659089     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

1.  Ischemic hepatitis induced by severe anemia.

Authors:  Miry Blich; Shimon Edelstein; Roy Mansano; Yeouda Edoute
Journal:  Isr Med Assoc J       Date:  2003-03       Impact factor: 0.892

2.  Hemodynamic pathogenesis of ischemic hepatic injury following cardiogenic shock/resuscitation.

Authors:  R W Bailey; M L Brengman; K C Fuh; S R Hamilton; H F Herlong; G B Bulkley
Journal:  Shock       Date:  2000-10       Impact factor: 3.454

3.  Liver function and splanchnic ischemia in critically ill patients.

Authors:  N D Maynard; D J Bihari; R N Dalton; R Beale; M N Smithies; R C Mason
Journal:  Chest       Date:  1997-01       Impact factor: 9.410

4.  Central and regional hemodynamics during crystalloid fluid therapy after uncontrolled intra-abdominal bleeding.

Authors:  L Riddez; L Johnson; R G Hahn
Journal:  J Trauma       Date:  1998-03

5.  C-reactive protein as an indicator of sepsis.

Authors:  P Póvoa; E Almeida; P Moreira; A Fernandes; R Mealha; A Aragão; H Sabino
Journal:  Intensive Care Med       Date:  1998-10       Impact factor: 17.440

6.  Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock.

Authors:  Roderick H Tung; Christine Garcia; Alexander M Morss; Richard M Pino; Michael A Fifer; B Taylor Thompson; Kent Lewandrowski; Elizabeth Lee-Lewandrowski; James L Januzzi
Journal:  Crit Care Med       Date:  2004-08       Impact factor: 7.598

7.  Ischemic hepatitis.

Authors:  T E Bynum; J K Boitnott; W C Maddrey
Journal:  Dig Dis Sci       Date:  1979-02       Impact factor: 3.199

Review 8.  B-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure.

Authors:  Vikas Bhalla; Scott Willis; Alan S Maisel
Journal:  Congest Heart Fail       Date:  2004 Jan-Feb

9.  Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients.

Authors:  Valentin Fuhrmann; Nikolaus Kneidinger; Harald Herkner; Gottfried Heinz; Mariam Nikfardjam; Anja Bojic; Peter Schellongowski; Bernhard Angermayr; Reinhard Kitzberger; Joanna Warszawska; Ulrike Holzinger; Peter Schenk; Christian Madl
Journal:  Intensive Care Med       Date:  2009-06-09       Impact factor: 17.440

10.  B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock.

Authors:  Anders Hejmdal; Søren Boesgaard; Matias G Lindholm; Jens Peter Goetze
Journal:  J Card Fail       Date:  2007-04       Impact factor: 5.712

View more
  2 in total

1.  Trends in deceased donor liver enzymes prior to transplant: The impact on graft selection and outcomes.

Authors:  Melissa G Kaltenbach; Michael O Harhay; Peter L Abt; David S Goldberg
Journal:  Am J Transplant       Date:  2019-09-24       Impact factor: 8.086

2.  Clinical Value of Circulating ZFAS1 and miR-590-3p in the Diagnosis and Prognosis of Chronic Heart Failure.

Authors:  Guannan Chang; Wenqing Zhang; Meicheng Zhang; Gang Ding
Journal:  Cardiovasc Toxicol       Date:  2021-07-28       Impact factor: 3.231

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.